CERS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Cerus Corporation · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 2.15 USD
-26.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -11.2% below the Trend Line and sits at 43.1% of its 52-week range. The latest completed week returned -26.6%, after a -32.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 58/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 3d.

Setup score 40 out of 100
Latest Close 2.15 USD 31 Jul 2026
1W Return -26.6% latest completed week
4W Return -32.0% short-term follow-through
12W Return -17.6% quarterly tape
Trend Breadth 73.1% 38 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -26.6% Latest completed week; four-week move -32.0%. Indicator stack 85/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 58/100 conviction; expected move 30.9%. News sentiment 53/100 63 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -11.2% below the Trend Line and sits at 43.1% of its 52-week range. The latest completed week returned -26.6%, after a -32.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.65

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -32.0% over four weeks, -17.6% over 12 weeks, and 69.3% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W-26.6%
4W-32.0%
12W-17.6%
26W-7.7%
52W69.3%
Active trend streak14 weeks
Active weeks in one year38
Trend breadth73.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.44Latest activity-pressure read.
Pressure change-53.0%Four-week change in activity pressure.
Leadership-3.72Latest relative-leadership reading.
RS change-108.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength15/100Blend of value, momentum, and quality. Underlying universe rank 86; rank 1 is best.
Value9/100Relative valuation strength. Underlying universe rank 92; rank 1 is best.
Quality16/100Profitability and accounting quality. Underlying universe rank 85; rank 1 is best.
Momentum95/100Medium-term price momentum. Underlying universe rank 6; rank 1 is best.
Growth79/100Revenue and earnings growth. Underlying universe rank 22; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.6x
Market value relative to trailing revenue.
EV / EBITDA
552.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.3%
Gross profit retained from each unit of revenue.
Operating margin
-0.5%
Operating profit retained from revenue.
Free-cash-flow margin
2.9%
Free cash flow generated from revenue.
Return on invested capital
-0.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
20.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-37.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
-0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
58.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CERS shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.24, expected move of 30.9%, and Sharemaestro trend signal active.

Conviction58/100
Expected move30.9%
Put/call volume0.24
Pressure71
Speculation45
Volatility96
Trend agreement34
Open options detail
Insider activity8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 63 relevant articles.

12 positive · 47 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move30.9%Nearest-chain priced movement where available.
52-week drawdown-38.0%Distance below the 52-week high.
13-week volatility11.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+37.4%Week of 1 May.
Worst week-26.6%Week of 31 Jul.
Latest week-26.6%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses1
Sharp losses10
Recent vol11.0%13-week weekly-return volatility.
Base vol10.7%52-week weekly-return volatility.
Up/down split28/22Count of positive and negative weeks in the 52-week window.
Average skew8.7% / -7.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis84/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.

Activity pressure 0.91; 2 reversal markers Factors30/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71; Small Cap Core rank 97 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

CERS shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.24, expected move of 30.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 30.9% Sentiment53/100

Weighted news tone is neutral across 63 relevant articles.

Cerus Q2 2026 Earnings Call Transcript Insiders8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.15 USD-26.6%2.42 USD1.85 USD0.44-3.7215.4MOn
24 Jul 20262.93 USD-6.4%2.41 USD1.85 USD0.8832.5812.0MOn
17 Jul 20263.13 USD0.3%2.38 USD1.85 USD1.0540.898.5MOn
10 Jul 20263.12 USD-1.3%2.35 USD1.85 USD1.0336.3013.0MOn
3 Jul 20263.16 USD8.2%2.32 USD1.84 USD0.9442.0012.7MOn
26 Jun 20262.92 USD8.1%2.28 USD1.84 USD0.8333.7018.9MOn
19 Jun 20262.70 USD5.5%2.24 USD1.83 USD0.7519.2110.1MOn
12 Jun 20262.56 USD-5.5%2.21 USD1.83 USD0.7516.8511.9MOn
5 Jun 20262.71 USD-10.9%2.18 USD1.83 USD0.6427.3911.9MOn
29 May 20263.04 USD12.2%2.14 USD1.83 USD0.6237.329.8MOn
22 May 20262.71 USD15.8%2.09 USD1.83 USD0.5927.3213.2MOn
15 May 20262.34 USD-10.3%2.05 USD1.82 USD0.1912.2211.3MOn
8 May 20262.61 USD-4.0%2.02 USD1.82 USD-0.0325.3815.1MOn
1 May 20262.72 USD37.4%1.99 USD1.81 USD-0.4238.7728.2MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.